Supplemental material
Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 2
Research Paper
Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States
Sandra E Talbirda Health Economics, RTI Health Solutions, Research Triangle Park, NC, USACorrespondence[email protected]
https://orcid.org/0000-0003-4719-3703View further author information
https://orcid.org/0000-0003-4719-3703View further author information, Elizabeth M Laa Health Economics, RTI Health Solutions, Research Triangle Park, NC, USAhttps://orcid.org/0000-0001-5652-8961View further author information
https://orcid.org/0000-0001-5652-8961View further author information, Justin Carricoa Health Economics, RTI Health Solutions, Research Triangle Park, NC, USAhttps://orcid.org/0000-0002-4659-9309View further author information
https://orcid.org/0000-0002-4659-9309View further author information, Sara Postonb US Health Outcomes & Epidemiology, Vaccines, GSK, Philadelphia, PA, USAhttps://orcid.org/0000-0003-4735-057XView further author information
https://orcid.org/0000-0003-4735-057XView further author information, Jean-Etienne Poirrierb US Health Outcomes & Epidemiology, Vaccines, GSK, Philadelphia, PA, USAhttps://orcid.org/0000-0002-1246-7746View further author information
https://orcid.org/0000-0002-1246-7746View further author information, Jessica K DeMartinob US Health Outcomes & Epidemiology, Vaccines, GSK, Philadelphia, PA, USAhttps://orcid.org/0000-0002-4685-3450View further author information
https://orcid.org/0000-0002-4685-3450View further author information & Cosmina S Hogeac Global Value Evidence and Outcomes, Oncology,GSK, Philadelphia, PA, USAhttps://orcid.org/0000-0002-0686-2395View further author information
https://orcid.org/0000-0002-0686-2395View further author information show all